Bacterial Culture Underestimates Lung Pathogen Detection and Infection Status in Cystic Fibrosis
- PMID: 35972283
- PMCID: PMC9602735
- DOI: 10.1128/spectrum.00419-22
Bacterial Culture Underestimates Lung Pathogen Detection and Infection Status in Cystic Fibrosis
Abstract
Microbiological surveillance of airway secretions is central to clinical care in cystic fibrosis (CF). However, the efficacy of microbiological culture, the diagnostic gold standard for pathogen detection, has been increasingly questioned. Here we compared culture with targeted quantitative PCR (QPCR) for longitudinal detection of 2 key pathogens, Pseudomonas aeruginosa and Staphylococcus aureus. Prospectively collected respiratory samples taken from 20 pediatric and 20 adult CF patients over a period of 3-years were analyzed. Patients were eligible if considered free of chronic Pseudomonas infection within 12-months prior to start of study. QPCR revealed high levels of infection with both pathogens not apparent from culture alone. Pseudomonas and Staphylococcus were detected by culture on at least one sampling occasion in 12 and 29 of the patients, respectively. Conversely, both pathogens were detected in all 40 patients by QPCR. Classification of infection status also significantly altered in both pediatric and adult patients, where the number of patients deemed chronically infected with Pseudomonas and Staphylococcus increased from 1 to 28 and 9 to 34, respectively. Overall, Pseudomonas and Staphylococcus infection status classification changed respectively for 36 and 27 of all patients. In no cases did molecular identification lead to a patient being in a less clinically serious infection category. Pathogen detection and infection status classification significantly increased when assessed by QPCR in comparison to culture. This could have implications for clinical care of CF patients, including accuracy of infection diagnosis, relevant and timely antibiotic selection, antimicrobial resistance development, establishment of chronic infection, and cross-infection control. IMPORTANCE Chronic lung infection is the leading cause of morbidity and early mortality for people with cystic fibrosis (pwCF). Microbiological surveillance to detect lung pathogens is recommended as best practise in CF patient care. Here we studied pathogen detection in 40 pwCF over several years. We found that microbiological culture, the diagnostic gold standard, was significantly disparate to targeted culture-independent approaches for detection and determination of chronic infection status of two important pathogens in CF. Pathogen detection was significantly lower by culture and consequently infection status was also misclassified in most cases. In particular, the extent of chronic infection by both P. aeruginosa and S. aureus not realized with culture was striking. Our findings have implications for the development of infection and clinical care of pwCF. Future longitudinal studies with greater patient numbers will be needed to establish the full extent of the clinical implications indicated from this study.
Keywords: Pseudomonas aeruginosa; QPCR; Staphylococcus aureus; chronic infection; infection status; lung infection.
Conflict of interest statement
The authors declare a conflict of interest. All authors declare support from the CF Trust. A.H. reports personal fees for advisory services (Mylan Pharmaceuticals) and educational and presentation activities (Vertex Pharmaceuticals).
Figures
References
-
- Pillarisetti N, Williamson E, Linnane B, Skoric B, Robertson CF, Robinson P, Massie J, Hall GL, Sly P, Stick S, Ranganathan S, Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF) . 2011. Infection, inflammation, and lung function decline in infants with cystic fibrosis. Am J Respir Crit Care Med 184:75–81. doi: 10.1164/rccm.201011-1892OC. - DOI - PubMed
-
- Cystic Fibrosis Foundation. 2019. Cystic Fibrosis Foundation Patient Registry 2019 Annual Data Report. Cystic Fibrosis Foundation, Bethesda, Maryland, USA. https://www.cff.org/sites/default/files/2021-10/2019-Patient-Registry-An....
-
- Cystic Fibrosis Trust. 2019. UK Cystic Fibrosis Registry Annual Data Report 2019. Cystic Fibrosis Trust, London, UK. https://www.cysticfibrosis.org.uk/sites/default/files/2020-12/2019%20Reg....
-
- Public Health England. 2019. Investigation of bronchoalveolar lavage, sputum and associated specimens. UK Standard for Microbiology Investigations, England. B 57 Issue 3.5. https://assets.publishing.service.gov.uk/government/uploads/system/uploa....
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical
